folfirinox Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Phase 2/3 (1)

Interventional (2)

Blokhin's Russian Cancer Research Center (1)
James Cleary, MD, PhD (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadcombination chemotherapy

I am/have/hadgastrointestinal neoplasms

I am/have/hadmetastasis

I am/have/hadHIV Infection

I am/have/hadhepatitis b

I am/have/hadimmunodeficiency

I am/have/hadgastric tumor

I am/have/hadflot regimen

I am/have/hadneutrophil count

I am/have/hadadenocarcinoma

I am/have/hadhepatitis

I am/have/hadstomach neoplasm

I am/have/hadflot

I am/have/hadgastric adenocarcinoma

I am/have/hadabsolute neutrophil count

I am/have/hadadenocarcinoma of the gastroesophageal junction

I am/have/hadcytostatic chemotherapy

added new label for I am/have/had

more

I am looking for

I am looking foroxaliplatin

I am looking forfolfirinox

I am looking foririnotecan

I am looking forcytostatic

I am looking forleucovorin

I am looking forfluorouracil

I am looking forcombinations

I am looking fordocetaxel

I am looking forhepatitis b

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

Featured trial

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Switch Maintenance in Pancreatic

This study is being done to test the safety and effectiveness of combining domvanalimab (AB154), zimberelimab (AB122), and APX005M with pancreatic cancer that has spread to other parts of body.This research study involves immunotherapy. Immunotherapy triggers the body's immune system to fight cancer cells.The names of the study drugs involved …

0 views
24 Nov, 2025
1 location

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma

One half of the patients gets 5-Fluorouracil (5-FU), Leucovorin, Oxaliplatin and Docetaxel (FLOT), the others 5-Fluorouracil (5-FU), Leucovorin, Oxaliplatin and Irinotecan (FOLFIRINOX). Main objective of the study is median overall survival.

oxaliplatin

combination chemotherapy

metastasis

gastrointestinal neoplasms

HIV Infection

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.